Kura Oncology stock soars toward record high after lymphoma drug achieves goal
Shares of Kura Oncology Inc.
soared 27% toward a record high in premarket trading Friday, after the biopharmaceutical company announced a phase 2 trial of its lymphoma treatment achieved its primary efficacy endpoint. The stock was on track to open above its March 2, 2018 record close of $23.40.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
CrowdStrike stock soars more than 80% after IPOShares of CrowdStrike Holdings Inc. jumped nearly 87% on Wednesday morning as the cybersecurity stock made its trading debut. The first trade was executed at...
Consulte Mais informação »
DryShips' stock soars after receipt of buyout proposal by company controlled by CEO George EconomouShares of DryShips Inc. rocketed 26% in active premarket trade Thursday, after the cargo ship operator said it received a buyout proposal from SPII Holdings...
Consulte Mais informação »
Callaway Golf's stock soars after activist discloses big stake and pushes for saleShares of Callaway Golf are soaring on the first day of action at the US Open, but not because of anything happening at Pebble Beach. Activist investor Jana Partners disclosed a big stake in Callaway, and it's pushing for a sale of the company.
Consulte Mais informação »
Alibaba Takes New Step Towards Hong Kong Stock Listing (Report)Chinese e-commerce giant Alibaba may have secretly made an application for a secondary listing of its shares on the Hong Kong Stock Exchange, according to a report Thursday from Bloomberg. The comp…
Consulte Mais informação »
'Stranger Things'' Hawkins High Is Getting the Nike TreatmentNike is redesigning its timeless Cortez, Blazer Mid, Air Tailwind 79 sneakers to honor of Stranger Things 3 upcoming release.
Consulte Mais informação »